24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
BiondVax
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
21:22
Who's cashing out in eToro’s IPO? Founders, ministers, and moguls eye big gains
17:25
eToro files for $240M Wall Street IPO at over $4B valuation after brief pause
14:52
"Our entrepreneurs are building the country with world-class, groundbreaking technologies"
14:39
"Startups can see TikTok as the world's largest focus group"
More stories
Buzz
Most popular
Daily
Weekly
1
The 50 most promising Israeli startups - 2025
2
The female founders shaping Israel’s startup scene in 2025
3
“We’re looking at another year or two of pain and uncertainty before a new growth cycle begins”
4
April 2025 in Israeli tech funding: Over $455 million in 19 deals
5
eToro files for $240M Wall Street IPO at over $4B valuation after brief pause
More news
BiondVax
2 stories about BiondVax
Flu Season Might Soon Pass, for Good
11.12.19
|
Lilach Baumer
The researchers behind Jerusalem-based BiondVax talked to Calcalist, discussing their potential universal flu vaccine, currently undergoing a phase 3 clinical trial
Marius Nacht Buys Controlling Stake in Universal Flu Vaccine Developer BiondVax
17.07.19
|
Micky Grunfeld
Based in Jerusalem, Nasdaq-listed BiondVax develops a universal flu vaccine, currently in advanced clinical trials